Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127764442 | 12776444 | 2 | F | 20151221 | 20160927 | 20160923 | 20160928 | EXP | AU-ABBVIE-16P-008-1733768-00 | ABBVIE | 0.00 | Y | 0.00000 | 20160928 | OT | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127764442 | 12776444 | 1 | PS | LOPINAVIR/RITONAVIR | LOPINAVIRRITONAVIR | 1 | Transplacental | D | 21226 | 1 | DF | QID | |||||||
127764442 | 12776444 | 2 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | D | 0 | 1 | DF | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127764442 | 12776444 | 1 | Maternal exposure timing unspecified |
127764442 | 12776444 | 2 | Maternal exposure timing unspecified |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127764442 | 12776444 | OT |
127764442 | 12776444 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127764442 | 12776444 | Foetal exposure during pregnancy | |
127764442 | 12776444 | Foetal growth restriction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |